These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 4189)

  • 1. Towards rational therapy with monoamine oxidase inhibitors.
    Tyrer P
    Br J Psychiatry; 1976 Apr; 128():354-60. PubMed ID: 4189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of MAOI antidepressants.
    Ravaris CL; Robinson DS; Nies A; Ives JO; Bartlett D
    Am Fam Physician; 1978 Jul; 18(1):105-11. PubMed ID: 665471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologic treatment of phobic disorders.
    Noyes R; Chaudry DR; Domingo DV
    J Clin Psychiatry; 1986 Sep; 47(9):445-52. PubMed ID: 2875063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoamine oxidase inhibitors and alprazolam in the treatment of panic disorder and agoraphobia.
    Sheehan DV
    Psychiatr Clin North Am; 1985 Mar; 8(1):49-62. PubMed ID: 2859580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Are the MAOIs outmoded?].
    Van Renynghe G
    Acta Psychiatr Belg; 1972 Nov; 72(6):767-88. PubMed ID: 4679553
    [No Abstract]   [Full Text] [Related]  

  • 6. Reversible and irreversible monoamine oxidase inhibitors in other psychiatric disorders.
    Liebowitz MR; Hollander E; Schneier F; Campeas R; Welkowitz L; Hatterer J; Fallon B
    Acta Psychiatr Scand Suppl; 1990; 360():29-34. PubMed ID: 2248064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacotherapeutic considerations in anxiety disorders.
    Hollister LE
    J Clin Psychiatry; 1986 Jun; 47 Suppl():33-6. PubMed ID: 2872208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MAOIs: impact on social behavior.
    Liebowitz MR; Campeas R; Hollander E
    Psychiatry Res; 1987 Sep; 22(1):89-90. PubMed ID: 3659222
    [No Abstract]   [Full Text] [Related]  

  • 9. Benzodiazepines in depressive disorders.
    Schatzberg AF; Cole JO
    Arch Gen Psychiatry; 1978 Nov; 35(11):1359-65. PubMed ID: 30428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delineation of anxiety and phobic disorders responsive to monoamine oxidase inhibitors: implications for classification.
    Sheehan DV
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):29-36. PubMed ID: 6429129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining an appropriate management strategy for social anxiety disorder.
    Davidson JR
    Int Clin Psychopharmacol; 2000 Jul; 15 Suppl 1():S13-7. PubMed ID: 10994678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The present status of monoamine oxidase inhibitors.
    Pare CM
    Br J Psychiatry; 1985 Jun; 146():576-84. PubMed ID: 3893604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Psycholopharmacology": the use of drugs combined with psychological treatment.
    Marks IM
    Proc Annu Meet Am Psychopathol Assoc; 1976; (64):108-26. PubMed ID: 4789
    [No Abstract]   [Full Text] [Related]  

  • 14. The rational use of anxiolytics.
    Bianchi GN
    N Z Med J; 1976 May; 83(563):303-8. PubMed ID: 8750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical use of psychotherapeutic drugs in the elderly.
    de Groot MH
    Drugs; 1974; 8(2):132-8. PubMed ID: 4154836
    [No Abstract]   [Full Text] [Related]  

  • 16. Guide to practical clinical psychopharmacology.
    Evans BD
    Pa Med; 1979 Apr; 82(4):34-8. PubMed ID: 35774
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug treatment of phobias. Efficacy and optimum use.
    Levin AP; Liebowitz MR
    Drugs; 1987 Oct; 34(4):504-14. PubMed ID: 2890514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Some current treatment options for symptoms of anxiety.
    Shader RI; Greenblatt DJ
    J Clin Psychiatry; 1983 Nov; 44(11 Pt 2):21-30. PubMed ID: 6139367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative double-blind clinical trial of SB 5833 and temazapam].
    Porta V; Jann G; Delzanno GB
    Brux Med; 1974 Nov; 54(11):655-8. PubMed ID: 4155344
    [No Abstract]   [Full Text] [Related]  

  • 20. [The characteristics of treating social phobia].
    Iakovlev VA
    Voen Med Zh; 1998 Jan; 319(1):54-6. PubMed ID: 9505549
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.